In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AusAm Biotechnologies Inc.

Latest From AusAm Biotechnologies Inc.

Start-Up Previews (12/03)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Therapeutic Antibodies, features profiles of Acceptys Inc., KaloBios Inc. and Rinat Neuroscience Corp. Plus these Start-Ups Across Health Care: Atritech Inc, AusAm Biotechnologies Inc., Cenix BioScience GMBH and TransOral Pharmaceuticals Inc.

AusAm Biotechnologies Inc.

Three-year-old AusAm Biotechnologies is actively pursuing both diagnostics and therapeutics, with all novel technologies based on its founding scientists' observations about the kidney. In diagnostics, it recently received FDA clearance for a highly sensitive test that detects precursors to kidney disease. The test has potential to become a wide screen, particularly for at-risk diabetics. In therapeutics, it is developing a polysaccharide-based class of anti-viral attachment inhibitors, which have potential in treatment of infectious diseases like AIDs, encephalitis and small pox.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Pharmaceuticals